使用直接作用抗病毒药物获得持续病毒学应答的 HCV 引起的肝硬化补偿患者肝细胞癌的临床流行病学研究。

Dina Abdallah, Mohamed Farghaly, Mona Abdelmaksoud, Mai Ghanem, Mohamed Mohamed, Ibrahim Ibrahim
{"title":"使用直接作用抗病毒药物获得持续病毒学应答的 HCV 引起的肝硬化补偿患者肝细胞癌的临床流行病学研究。","authors":"Dina Abdallah, Mohamed Farghaly, Mona Abdelmaksoud, Mai Ghanem, Mohamed Mohamed, Ibrahim Ibrahim","doi":"10.21608/aeji.2024.264655.1352","DOIUrl":null,"url":null,"abstract":"HCC in general. Conclusion: Frequency of HCC is still high among DAAs treated HCV induced compensated cirrhotic patients with SVR and the 6 monthly follow up by AFP and pelviabdominal ultrasound in these patients is mandatory.","PeriodicalId":504099,"journal":{"name":"Afro-Egyptian Journal of Infectious and Endemic Diseases","volume":"327 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinicoepidemiologic Study of Hepatocellular Carcinoma among HCV Induced Compensated Cirrhotic Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Drugs.\",\"authors\":\"Dina Abdallah, Mohamed Farghaly, Mona Abdelmaksoud, Mai Ghanem, Mohamed Mohamed, Ibrahim Ibrahim\",\"doi\":\"10.21608/aeji.2024.264655.1352\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"HCC in general. Conclusion: Frequency of HCC is still high among DAAs treated HCV induced compensated cirrhotic patients with SVR and the 6 monthly follow up by AFP and pelviabdominal ultrasound in these patients is mandatory.\",\"PeriodicalId\":504099,\"journal\":{\"name\":\"Afro-Egyptian Journal of Infectious and Endemic Diseases\",\"volume\":\"327 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Afro-Egyptian Journal of Infectious and Endemic Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/aeji.2024.264655.1352\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Afro-Egyptian Journal of Infectious and Endemic Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/aeji.2024.264655.1352","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

一般的 HCC。结论:在接受DAAs治疗的HCV诱导的代偿期肝硬化 SVR患者中,HCC的发生率仍然很高,因此必须对这些患者进行每月6次的AFP和盆腹腔超声随访。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Clinicoepidemiologic Study of Hepatocellular Carcinoma among HCV Induced Compensated Cirrhotic Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Drugs.
HCC in general. Conclusion: Frequency of HCC is still high among DAAs treated HCV induced compensated cirrhotic patients with SVR and the 6 monthly follow up by AFP and pelviabdominal ultrasound in these patients is mandatory.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信